Dexcom Shows Off More G7 Data

The newly published data solidifies the G7 as an improvement over the G6 and supports its potential as a 14-day wearable.

Dexcom G7
• Source: Alamy

Another set of data supporting the safety and accuracy of DexCom’s G7 continuous glucose monitor (CGM) is now published in Diabetes Technology & Therapeutics.

The 10-and-a-half day experiment included 316 participants with both type I and type II diabetes partake in in-clinic visits on days 1 or 2, 4 or 7, and 10 or 11 for the purpose of performing clinical-grade blood glucose measurements

More from Diabetic Care

More from Device Area